These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23990458)

  • 1. Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.
    Zhang W; Yan B; Jiang L
    Tumour Biol; 2013 Dec; 34(6):3989-93. PubMed ID: 23990458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.
    Shen XY; Lu FZ; Wu Y; Zhao LT; Lin ZF
    PLoS One; 2013; 8(8):e69553. PubMed ID: 23940523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
    Qiu M; Xu L; Yang X; Ding X; Hu J; Jiang F; Xu L; Yin R
    PLoS One; 2013; 8(10):e77005. PubMed ID: 24116196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
    Liu J; Zhou Z; Lai T; Yin J
    Tumour Biol; 2014 Feb; 35(2):1083-7. PubMed ID: 24061639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
    Wang Z; Zhang W
    Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
    Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
    Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
    Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
    Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.
    Bei L; Xiao-Dong T; Yu-Fang G; Jian-Ping S; Zhao-Yu Y
    Bull Cancer; 2015 Apr; 102(4):332-9. PubMed ID: 25794597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
    Xu YH; Gu LP; Sun YJ; Cheng BJ; Lu S
    Tumour Biol; 2013 Apr; 34(2):865-74. PubMed ID: 23300009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
    Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
    Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the XRCC1 and XRCC3 genetic polymorphisms on the efficacy of platinum-based chemotherapy in patients with advanced non-small cell lung cancer].
    Xu C; Wang X; Zhang Y; Li L
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):912-7. PubMed ID: 22152690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
    Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B
    BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.
    Xing ZS; Zhu G; Yang YL; Feng GQ; Ding GC
    Asian Pac J Trop Med; 2014 Jun; 7(6):483-7. PubMed ID: 25066399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
    Jin ZY; Zhao XT; Zhang LN; Wang Y; Yue WT; Xu SF
    Genet Mol Res; 2014 Mar; 13(3):7617-25. PubMed ID: 24737519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC3 Thr241Met polymorphism and risk of acute myeloid leukemia in a Romanian population.
    Bănescu C; Tilinca M; Benedek EL; Demian S; Macarie I; Duicu C; Dobreanu M
    Gene; 2013 Sep; 526(2):478-83. PubMed ID: 23747401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
    Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.
    Chen X; Sun H; Ren S; Kim Curran V; Zhang L; Zhou S; Zhang J; Zhou C
    Clin Transl Oncol; 2012 Mar; 14(3):207-13. PubMed ID: 22374424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.
    Sun H; Qiao Y; Zhang X; Xu L; Jia X; Sun D; Shen C; Liu A; Zhao Y; Jin Y; Yu Y; Bai J; Fu S
    Cancer Sci; 2010 Aug; 101(8):1777-82. PubMed ID: 20500515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of X-ray cross-complementing group 3 Thr241Met gene polymorphism with osteosarcoma risk and its development and prognosis.
    Wang Y; Wang G; Dong Z
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1178-S1182. PubMed ID: 30539867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.